1. Home
  2. JNPR vs ITCI Comparison

JNPR vs ITCI Comparison

Compare JNPR & ITCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JNPR
  • ITCI
  • Stock Information
  • Founded
  • JNPR 1996
  • ITCI 2002
  • Country
  • JNPR United States
  • ITCI United States
  • Employees
  • JNPR N/A
  • ITCI N/A
  • Industry
  • JNPR Computer Communications Equipment
  • ITCI Biotechnology: Pharmaceutical Preparations
  • Sector
  • JNPR Telecommunications
  • ITCI Health Care
  • Exchange
  • JNPR Nasdaq
  • ITCI Nasdaq
  • Market Cap
  • JNPR 11.9B
  • ITCI 13.5B
  • IPO Year
  • JNPR 1999
  • ITCI N/A
  • Fundamental
  • Price
  • JNPR $35.99
  • ITCI $131.88
  • Analyst Decision
  • JNPR Buy
  • ITCI Buy
  • Analyst Count
  • JNPR 6
  • ITCI 13
  • Target Price
  • JNPR $39.80
  • ITCI $106.58
  • AVG Volume (30 Days)
  • JNPR 3.1M
  • ITCI 2.0M
  • Earning Date
  • JNPR 04-24-2025
  • ITCI 05-06-2025
  • Dividend Yield
  • JNPR 2.44%
  • ITCI N/A
  • EPS Growth
  • JNPR N/A
  • ITCI N/A
  • EPS
  • JNPR 0.86
  • ITCI N/A
  • Revenue
  • JNPR $5,073,600,000.00
  • ITCI $680,852,000.00
  • Revenue This Year
  • JNPR $9.41
  • ITCI $40.64
  • Revenue Next Year
  • JNPR $3.95
  • ITCI $58.53
  • P/E Ratio
  • JNPR $42.00
  • ITCI N/A
  • Revenue Growth
  • JNPR N/A
  • ITCI 46.62
  • 52 Week Low
  • JNPR $33.72
  • ITCI $64.09
  • 52 Week High
  • JNPR $39.79
  • ITCI $131.87
  • Technical
  • Relative Strength Index (RSI)
  • JNPR 50.32
  • ITCI 85.59
  • Support Level
  • JNPR $35.98
  • ITCI $131.19
  • Resistance Level
  • JNPR $36.26
  • ITCI $131.79
  • Average True Range (ATR)
  • JNPR 0.24
  • ITCI 0.13
  • MACD
  • JNPR 0.05
  • ITCI -0.41
  • Stochastic Oscillator
  • JNPR 78.20
  • ITCI 91.18

About JNPR Juniper Networks Inc.

Juniper Networks Inc is engaged in designing, developing, and selling products and services for high-performance networks to enable customers to build scalable, reliable, secure, and cost-effective networks for their businesses while achieving agility and improved operating efficiency through automation. The company's high-performance network and service offerings include routing, switching, Wi-Fi, network security, artificial intelligence (AI) or AI-enabled enterprise networking operations (AIOps), and software-defined networking (SDN) technologies. In addition to the company's products, the company offers its customers a variety of services, including maintenance and support, professional services, Software-as-a-Service ("SaaS"), and education and training programs.

About ITCI Intra-Cellular Therapies Inc.

Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.

Share on Social Networks: